A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults.
about
Pertussis: Microbiology, Disease, Treatment, and Prevention.Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type B vaccine; Infanrix™ hexa: twelve years of experience in Italy.Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine admiVaccination recommendations for Germany.Evaluation of a new syringe presentation of reduced-antigen content diphtheria, tetanus, and acellular pertussis vaccine in healthy adolescents--A single blind randomized trial.Does tetanus-diphtheria-acellular pertussis vaccination interfere with serodiagnosis of pertussis infection?Safety of Tdap vaccine in pregnant women: an observational study.Forecasting Epidemiological Consequences of Maternal Immunization.Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine, adsorbed (boostrix(®)): a guide to its use as a single-dose booster immunization against pertussis.Protecting Newborns Against Pertussis: Treatment and Prevention Strategies.Immune persistence after pertussis vaccination.Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012.Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia
P2860
Q30251684-238602D4-EC0C-48B7-831C-D5AADF21C0AEQ34271528-0010CD74-651D-4D04-B444-DA8B24471907Q35122801-E6E16575-769A-45F4-9E9C-B5B13D45C06BQ35591138-2099D233-9C1F-4870-A74D-5CFF97667823Q35887172-8CE7AD64-1F5C-4C96-94CA-46E5E288236AQ36017781-8C5E6E4A-6E59-495D-8E3E-751EDBF4F8E8Q36818929-EEBBAA78-3A5F-4E7C-8464-5C994A4A94AEQ37410327-6B5C6CA7-3729-4BA1-A12D-F7C32AEE59DCQ38038906-3650901F-D588-40A5-974E-09FEA7507CB9Q38074886-D73D0D28-93E7-4252-B624-9DB38502FF2BQ38626455-C1FA4843-E1C0-4EBD-8B5A-1BA6DA75AFB3Q38775297-B7D8DAB1-8F84-4D98-ADA9-C09486741748Q45909451-6A83B809-548F-4587-8EFD-7D192B018184Q52558356-C2CD0268-FD9F-4D0A-BD70-FCC8A2745B1CQ57812045-1FCAA9FA-04CA-4DB7-912F-7C72A0B41435
P2860
A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
A decennial booster dose of re ...... and well tolerated in adults.
@en
A decennial booster dose of re ...... and well tolerated in adults.
@nl
type
label
A decennial booster dose of re ...... and well tolerated in adults.
@en
A decennial booster dose of re ...... and well tolerated in adults.
@nl
prefLabel
A decennial booster dose of re ...... and well tolerated in adults.
@en
A decennial booster dose of re ...... and well tolerated in adults.
@nl
P2093
P1433
P1476
A decennial booster dose of re ...... and well tolerated in adults.
@en
P2093
Froilan Celzo
Gunasekaran Ramakrishnan
Jeanne-Marie Jacquet
Olivier Van der Meeren
Robert Booy
Su-Peing Ng
P356
10.1016/J.VACCINE.2010.10.025
P407
P577
2010-10-23T00:00:00Z